Linq Therapeutics Private Limited

Linq Therapeutics Private Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999PN2015PTC156595 Incorporated 29 September 2015 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company healthcare MSME · Micro
Revenue · FY 2024
₹95.69 Lakh
▼ 26% YoY
Net profit · FY 2024
₹3.25 Lakh
Net margin 3.4%
EBITDA · FY 2024
₹7.5 Lakh
EBITDA margin 7.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
2
Provident fund records
Directors on board
5
As per MCA filings

About Linq Therapeutics Private Limited

Data last updated:

Linq Therapeutics Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 September 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2015PTC156595. Its GSTIN is 27AACCL9382M1ZT (Maharashtra).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Pathik Pradeep Divate and Uma Pradeep Divate.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹95.69 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹3.25 Lakh (net margin 3.4%) and EBITDA of ₹7.5 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 17% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Linq Labs.

Linq Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0095873). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website linqlabs.com.

Company details

CIN U74999PN2015PTC156595
Registration Number 156595
Incorporation Date 29 September 2015
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0095873

Recognitions & Rankings of Linq Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-26-0095873

Contact details

Linq Therapeutics Private Limited's registered office is in Pune, Maharashtra. Its website is linqlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Office No. 309 – 311 Millenium Star, P 17 Fp 153 Cts 36 To 40 Sangamwadi, Pune, Maharashtra, India – 411001
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Linq Therapeutics Private Limited, buy the company report.

Comprehensive company report
Linq Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Linq Therapeutics operates one associated brand: Linq Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Business IT solutions and accounting services for operations are provided.linqlabs.com

Business activity

The main business activity of Linq Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Linq Therapeutics Private Limited, buy the company report.

Financials of Linq Therapeutics Private Limited

FY 2025 filings available

Linq Therapeutics Private Limited reported revenue of ₹95.69 Lakh (down 26% YoY) for FY 2024.

Revenue · FY 2024
₹95.69 Lakh ▼ 26%
Net profit · FY 2024
₹3.25 Lakh margin 3.4%
EBITDA · FY 2024
₹7.5 Lakh margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 26%
3 years · compounded
▲ 3%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 42%
5 years · compounded
▲ 21%

Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.5 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.25 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin7.8%
Net Profit Margin3.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Linq Therapeutics Private Limited, buy the company report.

Board of directors of Linq Therapeutics Private Limited

Linq Therapeutics has 5 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Pathik Pradeep DivateDirector29 Sep 201511 Years 1 MonthsCurrent
Uma Pradeep DivateDirector29 Sep 201511 Years 1 MonthsCurrent
Cowasji Jehangir JehangirDirector25 Nov 20205 Years 11 MonthsCurrent
Jehangir Hirji Cawasji JehangirDirector29 Sep 201511 Years 1 MonthsCurrent
Geeta Pathik DivateDirector25 Nov 20205 Years 11 MonthsCurrent

Auditor

Linq Therapeutics Private Limited is audited by PATANKAR & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
PATANKAR & ASSOCIATESFY 2019107628W

Shareholding

The shareholding of Linq Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Linq Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Linq Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Linq Therapeutics Private Limited has a workforce of 2 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1
Employee growth
-60%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-272
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Linq Therapeutics Private Limited, buy the company report.

GST

Linq Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AACCL9382M1ZTMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Linq Therapeutics Private Limited, buy the company report.

Recent activity

Linq Therapeutics Private Limited has 5 board changes on record since 2015: 5 appointments. The latest: Cowasji Jehangir Jehangir was appointed as Director on 25 Nov 2020.

AGM
Linq Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Linq Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Cowasji Jehangir Jehangir was appointed as Director.
Appointed
Geeta Pathik Divate was appointed as Director.
Appointed
Jehangir Hirji Cawasji Jehangir was appointed as Director.
Appointed
Pathik Pradeep Divate was appointed as Director.
Appointed
Uma Pradeep Divate was appointed as Director.
Incorporation
29 Sep 2015
Linq Therapeutics Private Limited was registered on 29 Sep 2015 with Roc Pune & aged 11 years 1 month as per MCA records.

Frequently asked questions

Linq Therapeutics is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 September 2015 (11+ years old) and is registered under CIN U74999PN2015PTC156595.

Linq Therapeutics has 5 current directors:

The latest financial statements of Linq Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Linq Therapeutics is 27AACCL9382M1ZT, registered in Maharashtra.

The CIN (Corporate Identification Number) of Linq Therapeutics is U74999PN2015PTC156595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Linq Therapeutics was incorporated on 29 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.

Cowasji Jehangir Jehangir was appointed as Director on 25 Nov 2020. Geeta Pathik Divate was appointed as Director on 25 Nov 2020. Jehangir Hirji Cawasji Jehangir was appointed as Director on 29 Sep 2015. Linq Therapeutics has 5 board changes on record in total.

Yes, Linq Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0095873).

Linq Therapeutics can be reached through the website linqlabs.com. Its registered office is in Pune, Maharashtra, India.

The registered office of Linq Therapeutics is at Office No. 309 – 311 Millenium Star, P 17 Fp 153 Cts 36 To 40 Sangamwadi, Pune, Maharashtra, India – 411001.